Pierandrea Muglia

Pierandrea Muglia

Chief Tech/Sci/R&D Officer at SANA AB

Net worth: 428 580 $ as of 31/05/2026

60 year
Health Technology
Transportation
Commercial Services

Profile

Pierandrea Muglia was the founder of GRIN Therapeutics, Inc., founded in 2021, and served as President from 2021 to 2022.
The current jobs include Chief Executive Officer at Ichnos SRL and Chief Medical Officer at Saniona AB starting in 2025.
Former jobs include Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A, Chief Marketing Officer at Handl Therapeutics BV, and Vice President at UCB Pharma SA (Belgium) from 2012 to 2019.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2024 259,999 ( 0.19% ) 428 580 $ 31/05/2026

Pierandrea Muglia active positions

CompaniesPositionStart
SANA AB Chief Tech/Sci/R&D Officer 10/03/2025

Former positions of Pierandrea Muglia

CompaniesPositionEnd
Founder 01/09/2022
Corporate Officer/Principal 01/10/2019
Sales & Marketing -
NTG NORDIC TRANSPORT GROUP A/S Director/Board Member 28/05/2010
See the detail of Pierandrea Muglia's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Transportation

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Pierandrea Muglia